2006 DEC 1 - (NewsRx.com) -- Research conducted in the United States has provided new information about breast cancer.
Study 1: Ganoderma lucidum (link to wikipedia) could be used as a suitable herb for chemoprevention and chemotherapy of breast cancer via down-regulation of estrogen receptor and NF-kappa B signaling...
The researchers concluded, "Collectively, these results suggest that G. lucidum inhibits proliferation of human breast cancer cells and contain biologically active compounds with specificity against estrogen receptor and NF-kappa B signaling, and implicate G. lucidum as a suitable herb for chemoprevention and chemotherapy of breast cancer."
Jiang and colleagues published their study in International Journal of Oncology (Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappa B signaling. Int J Oncol, 2006;29(3):695-703).
